Universe Pharmaceuticals (UPC) Intangibles (2020 - 2025)
Universe Pharmaceuticals (UPC) reported Intangibles of $473.9 million for Q3 2025, up 19.04% on a YoY basis from $398.1 million in Q3 2024, and up 19.04% sequentially from $398.1 million in Q3 2024.
Universe Pharmaceuticals (UPC) Intangibles (2020 - 2025) Analysis & Trends
Universe Pharmaceuticals (UPC) has 6 years of Intangibles data on file, last reported at $473.9 million in Q3 2025.
- For the quarter ending Q3 2025, Intangibles rose 19.04% year-over-year to $473.9 million; the trailing twelve-month figure through Sep 2025 stood at $473.9 million (up 19.04% YoY), and the FY2025 full-year result was $473.9 million, up 19.04% from the prior year.
- Intangibles rose to $473.9 million in Q3 2025, from $398.1 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $473.9 million in Q3 2025 to a low of $147652.0 in Q1 2024.
- A 5-year average of $109.2 million and a median of $222942.5 in 2022 frame the typical range for Intangibles.
- Across the five-year window, Intangibles slumped 100.0% in 2021 and jumped 148944.44% in 2024, its largest moves.
- Tracing UPC's Intangibles over 5 years: stood at $148584.0 in 2021, then soared by 84.39% to $273974.0 in 2022, then slipped by 2.5% to $267121.0 in 2023, then jumped by 148944.44% to $398.1 million in 2024, then advanced by 19.04% to $473.9 million in 2025.
- Business Quant data shows UPC's Intangibles at $473.9 million in Q3 2025, $398.1 million in Q3 2024, and $147652.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 78.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 473.93 Mn |
| Sep 30, 2024 | 398.13 Mn |
| Mar 31, 2024 | 147,652.00 |
| Sep 30, 2023 | 267,121.00 |
| Mar 31, 2023 | 160,470.00 |
| Sep 30, 2022 | 273,974.00 |
| Mar 31, 2022 | 178,764.00 |
| Sep 30, 2021 | 148,584.00 |
| Sep 30, 2020 | 174.78 Bn |